| Ms Adesuwa Izevbigie, LCPC | |
|
4355 Nicole Dr, Lanham, MD 20706-4349 | |
| (301) 429-2171 | |
| Not Available |
| Full Name | Ms Adesuwa Izevbigie |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 4355 Nicole Dr, Lanham, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174969992 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Adesuwa Izevbigie, LCPC 1304 Fairlakes Pl, Bowie, MD 20721-3100 Ph: (301) 318-0141 | Ms Adesuwa Izevbigie, LCPC 4355 Nicole Dr, Lanham, MD 20706-4349 Ph: (301) 429-2171 |
News Archive
Several studies being presented at the American College of Cardiology's 67th Annual Scientific Session demonstrate how the computer science technique known as machine learning can be used to accurately predict clinical outcomes in patients with known or potential heart problems.
Also, a study finds that Medicare patients leaving the hospital can't always remember what was wrong with them and how to follow up.
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online in the Journal of Infectious Diseases, a multi-institutional research team reports that treatment with the preparation, containing the spores of approximately 50 species of beneficial bacteria, successfully prevented recurrence of C. difficile infection (CDI) in patients with a history of multiple recurrent disease.
MindChild Medical, Inc. today announced that it has received clearance for its Pre-Marketing Notification (510(k)) from the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.
One hundred eighty thousand women will be diagnosed with breast cancer this year. Eighty thousand will start taking the drug tamoxifen to prevent the recurrence of their ER (estrogen receptor) positive breast cancers. The treatment is successful in two-thirds of the women who take it. Genelex Corporation (Seattle) is now offering Tamoxitest(TM) that could improve this success rate to greater than 90% by addressing both of the common causes of tamoxifen treatment failure.
› Verified 9 days ago
Bernice Thomas- El, CSC- A&D Counselor Medicare: Not Enrolled in Medicare Practice Location: 4601 Forbes Blvd, Lanham, MD 20706 Phone: 301-306-4590 Fax: 301-306-4591 | |
Nada S Wilson, Counselor Medicare: Not Enrolled in Medicare Practice Location: Vesta, 9301 Annapolis Rd, Lanham, MD 20706 Phone: 240-296-6300 | |
Natasha Miller, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4640 Forbes Blvd Ste 120h, Lanham, MD 20706 Phone: 301-388-5793 | |
Carl Scott, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7404 Executive Pl Ste 225b, Lanham, MD 20706 Phone: 240-929-4387 | |
Dr. Ajunwa Nwogu, PSYD Counselor Medicare: Not Enrolled in Medicare Practice Location: 9332 Annapolis Rd Ste 303a, Lanham, MD 20706 Phone: 240-241-0421 | |
Margaret O'brien, LC Counselor Medicare: Not Enrolled in Medicare Practice Location: 10123 Senate Dr, Support Services, Lanham, MD 20706 Phone: 301-459-9840 Fax: 301-459-9110 | |
Mrs. Sharilyn Denise Connally, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 9320 Annapolis Rd Ste 100, Lanham, MD 20706 Phone: 301-577-8152 |